Instrument Inactif

Communiqués Syneos Health, Inc.

Actions

SYNH

US87166B1026

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Syneos Health : Releases 2023 Environmental, Social and Governance Report	08/07	PU
Syneos Health Releases 2024 Dealmakers Intentions Survey	10/01	AQ
Syneos Health : Signs Agreement with University of the Sunshine Coast to Support Clinical Trials in Australia	18/12	PU
Syneos Health : Signs Agreement with P3 Research Ltd Network to Support Clinical Trials in New Zealand	03/11	PU
Syneos Health : Signs Agreement with GoBroad Healthcare Group to Support Clinical Trials in China	02/11	PU
Syneos Health Signs Agreement with Singapore General Hospital, Further Expanding Catalyst Site Program	30/10/23	AQ
Syneos Health Appoints Colin Shannon as Chief Executive Officer	04/10/23	AQ
Syneos Health Closes Transaction with Private Investment Firms	28/09/23	AQ
Syneos Health Names Terttu Haring President, Clinical Sites & Patients	26/09/23	AQ
The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH)	26/09/23	PR
SYNEOS 72 HOUR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options	23/09/23	PR
SYNEOS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. and Encourages Investors to Contact the Firm	23/09/23	BU
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (SYNH)	22/09/23	BU
Attention SYNH Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Syneos Health, Inc. (SYNH) and Encourages Investors to Contact the Firm	22/09/23	PR
SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit	21/09/23	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH	21/09/23	PR
Levi & Korsinsky Notifies Syneos Health, Inc.(SYNH) Investors of a Class Action Lawsuit and Upcoming Deadline	21/09/23	PR
SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit	19/09/23	PR
The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH)	19/09/23	PR
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - SYNH	18/09/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Syneos Health, Inc.

Actions

SYNH

US87166B1026

Communiqués

Filtres